TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. This presents an opportunity for Insilico Medicine to emerge as a winner during the biotech spring.” It has nominated eight preclinical candidates since 2021.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

Crunchbase News

MARCH 1, 2024

The quintet that did raise big were from three of the usual sectors — biotech, energy and AI — however one was from a sector we don’t normally see — a vertical farming agtech startup. Fervo Energy, a geothermal developer, locked up a big $244 million round led by shale oil and gas firm Devon Energy Corp.

Energy 100

Energy Biotech Artificial Intelligence Artificial Inteligence 100

Crunchbase News

MARCH 5, 2024

Figure , $675M, artificial intelligence: Sunnyvale, California-based Figure last week confirmed earlier reports that it had raised a huge $675 million round at a $2.6 The company is developing AI-enhanced robots that it hopes will be able to perform dangerous jobs and alleviate labor shortages. billion, per Crunchbase.

Games 83

Games Artificial Intelligence Artificial Inteligence Biotech 83

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 116

Biotech Generative AI Blockchain Energy 116

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Let’s see if April can continue the trend of a growing amount of large raises. This March certainly did not go out like a lamb, with seven rounds hitting $100 million or more in the final week.

Biotech 111

Biotech Artificial Intelligence Artificial Inteligence Energy 111

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 110

Biotech Generative AI Artificial Intelligence Artificial Inteligence 110

TechCrunch

MAY 20, 2022

With cloud-based servers and sophisticated, yet inexpensive, sensors both on the body and off, patients can be monitored at home more effectively than in a hospital, especially when the sensor data is analyzed with artificial intelligence (AI) and machine-learning technology. Opportunities for digital biomarkers.

Artificial Inteligence 231

Artificial Inteligence Artificial Intelligence Healthcare Technical Review 231

Crunchbase News

FEBRUARY 2, 2024

Kore.ai , $150M, artificial intelligence: Another week and another big round for a generative AI startup. The startup is not new to the AI scene — it’s a decade old — and offers an array of artificial intelligence-related tech from virtual assistants to no-code tools to build AI apps. billion, per Crunchbase.

Biotech 82

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 82

Crunchbase News

MAY 15, 2024

It also participated in the gigantic $1 billion raise by Xaira Therapeutics , a startup at the intersection of AI and biotech. Finally, it co-led enterprise browser developer Island ’s big $175 million Series D with Coatue that valued the company at $3 billion — doubling its last valuation from less than a year earlier.

Biotech 94

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 94

Crunchbase News

DECEMBER 8, 2023

Rockville, Maryland-based X-energy, a developer of advanced small modular nuclear reactors and fuel technology for clean energy, completed its Series C financing that totaled $235 million. X.AI , $135M, artificial intelligence: You may have heard Elon Musk has an artificial intelligence startup to compete with OpenAI.

Energy 67

Energy Artificial Inteligence Biotech Artificial Intelligence 67

Crunchbase News

MARCH 15, 2024

Applied Intuition , $250M, autonomous vehicles: Autonomous vehicle software developer Applied Intuition locked up a $250 million Series E valuing the company at $6 billion — a 67% uptick in value from its previous round. Like many biotech startups raising big money currently, Zephyr is bringing AI to the sector.

Biotech 99

Biotech Artificial Intelligence Artificial Inteligence Cloud 99

Crunchbase News

DECEMBER 21, 2023

Artificial intelligence was big in 2023 — and that could be the understatement of the year. The startup is building what it says will be the “largest AI cluster in the world” and has created large language models to allow people to interact with its AI-powered assistant called Pi, or Personal AI.

Artificial Inteligence 125

Artificial Inteligence Artificial Intelligence Generative AI Biotech 125

TechCrunch

AUGUST 15, 2022

In addition to biotech, Russek felt there also needed to be software and automation components. Finally, artificial intelligence-powered automation and engineering components are designed to remote-monitor the water quality, regulate temperature and oxygenation and feed the shrimp. So they created Atarraya, a U.S.-based

Technology 238

Technology Biotech Artificial Intelligence Artificial Inteligence 238

Crunchbase News

MAY 3, 2024

CoreWeave , $1.1B, artificial intelligence: Funding to AI-related startups increased slightly in Q1 2024 compared to Q4 2023, and that trend may continue in the second quarter based on this week’s big round. While a big AI round led the way, there were huge raises in energy, quantum computing, neuroscience and other sectors too.

Biotech 102

Biotech Energy Artificial Intelligence Artificial Inteligence 102

Crunchbase News

APRIL 3, 2024

Others include: Imbue , a startup that trains foundational models to develop AI agents, landed $200 million in a September Series B round at a valuation of more than $1 billion. San Francisco-based Replit , a developer platform that uses AI to complete code, has raised $222 million in known funding at a valuation of at least $1.2

Artificial Intelligence 117

Artificial Intelligence Artificial Inteligence CTO Coach Technical Review 117

Crunchbase News

FEBRUARY 7, 2024

Recurrent Energy , $500M, energy: This large round may have gone under the radar for many, but Austin, Texas-based Recurrent Energy secured a $500 million preferred equity investment from BlackRock. Kore.ai , $150M, artificial intelligence: Of course there’s a big round for a generative AI startup. billion in October 2022.

Energy 82

Energy Biotech Artificial Intelligence Artificial Inteligence 82

Crunchbase News

FEBRUARY 23, 2024

Recogni , $102M, artificial intelligence: Although most startup chipmakers have not seen much love from investors so far this year , Recogni seems to have bucked that trend. Hornblower also announced a reshuffling of some of its units, including trying to sell its overnight cruising business. Clearly a lot is going on.

Artificial Intelligence 100

Artificial Intelligence Artificial Inteligence Energy Backup 100

TechCrunch

SEPTEMBER 8, 2022

Catalog says its current prototype DNA computation and storage platform, or DNA writer, called Shannon, has demonstrated the potential of DNA computation and storage as a proof of concept, but it is a large machine that requires a significant amount of chemistry.

Storage 206

Storage Artificial Inteligence Data Chemicals 206

Existek

SEPTEMBER 28, 2023

With the major progress in all sub-domains of artificial intelligence, the demand for AI developers has tremendously increased. Moreover, the involvement of AI developers has been proven to play a prominent role in delivering sophisticated products and services. List of the Content What do AI developers do?

Artificial Inteligence 52

Artificial Inteligence Development How To Artificial Intelligence 52

Crunchbase News

MARCH 11, 2024

Last month, a16z seemed to have a thing for healthcare and biotech. The firm took part in a $70 million Series B for San Francisco-based Ambience Healthcare , a $170 million Series D for Richmond, California-based BioAge Labs and a huge $254 million round for South San Francisco-based blood-test developer Freenome.

Biotech 96

Biotech Artificial Intelligence Artificial Inteligence Healthcare 96

Crunchbase News

FEBRUARY 16, 2024

AI-enabled healthcare There’s a lot of funding for nascent companies at the intersection of artificial intelligence and healthcare. New York-based Jona wants to use artificial intelligence to uncover links between the microbiome and health. Without further ado, here are five of our top trends for seed-stage.

Construction 118

Construction Artificial Intelligence Artificial Inteligence Generative AI 118

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

CIO

SEPTEMBER 18, 2023

The latest piece in her reinvention story is Synchrony’s new Tech Apprenticeship for Artificial Intelligence, a full-time, 12-month program that balances on-the-job learning with instructor-led training, providing Chavarin with a pathway into one of the most coveted technology spaces despite her very nontraditional IT background.

Technical Review 340

Technical Review Pharmaceuticals Security Training 340

TechCrunch

NOVEMBER 18, 2021

The drug development space is continuing to attract more and more investment. Generate Biomedicines is touting a platform-based approach to drug development, but with its own spin: a focus on proteins. . Meanwhile, investment in AI-based drug development has also snowballed. Per a Stanford University 2020 report, it reached $13.9

Artificial Inteligence 211

Artificial Inteligence Artificial Intelligence Machine Learning Report 211

Crunchbase News

FEBRUARY 15, 2024

Money still coming Investors in the space — which is broad and includes several areas of sectors such as biotech, manufacturing and climate tech — agree that while there has undoubtedly been a slow down in investing, the wide breadth of deep tech and the importance of the problems it is looking to solve has kept money flowing.

Biotech 100

Biotech Artificial Intelligence Artificial Inteligence Energy 100

TechCrunch

APRIL 12, 2022

“Searching for the right solution led the team deep into machine learning techniques, which came with requirements to use large amounts of data and deliver robust models to production consistently … The techniques used were platformized, and the solution was used widely at Lyft.” ” Taking Flyte.

Artificial Inteligence 202

Artificial Inteligence Machine Learning Open Source Biotech 202

TechCrunch

APRIL 19, 2022

. “We use data combined from a large number of previously-run clinical trials. Our product is not an AI model — it’s a clinical trial,” CEO Charles Fisher told TechCrunch via email. “[Our] intention wasn’t to speed clinical trials — it was pure research into machine learning.

Pharmaceuticals 170

Pharmaceuticals Artificial Inteligence Development Machine Learning 170

TechCrunch

AUGUST 10, 2022

Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” Insilico uses machine learning to identify potential drug targets and eventually create the drug.

Chemicals 187

Chemicals Biotech Artificial Inteligence Pharmaceuticals 187

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. “Next year, we anticipate having our first drug candidate enter the late preclinical phase of development and regulatory work for an IND (investigational new drug) filing with the FDA, and starting the clinical trials in 2023.”

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

DECEMBER 20, 2023

Cortical Labs plans to use the money to commercialize its biological computer chips — referred to as DishBrain — which has already learned to play basic video games like Pong. Some think such a development could be the next advancement of AI, since human neurons have some advantages over their digital counterparts.

Biotech 115

Biotech Artificial Intelligence Artificial Inteligence Energy 115

TechCrunch

DECEMBER 15, 2021

Prellis Biologics , a company developing the tools to create 3D-printed organs, announced a $14.5 Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Matheu calls it “natural intelligence” as opposed to artificial intelligence. .

System 203

System Artificial Inteligence 3D Pharmaceuticals 203

TechCrunch

OCTOBER 20, 2021

Healx is one of a host of startups invested in using AI for drug development and identification. Healx’s platform, called Healnet , uses machine learning to crawl through data on existing drugs, and potential disease targets, to find new connections. AI-based drug development is becoming a bigger piece of the AI landscape.

Artificial Inteligence 243

Artificial Inteligence Study Artificial Intelligence Pharmaceuticals 243

TechCrunch

JANUARY 25, 2022

The Tunisian startup, headquartered in London with offices in Paris, Tunis, Lagos, Dubai and Cape Town, uses advanced machine learning techniques to bring AI to applications within an enterprise environment. The lab’s mandate was to deploy the latest advances in AI and ML to develop novel immunotherapies.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

Crunchbase News

JANUARY 8, 2024

In addition to AI, cleantech, biotech and next-generation manufacturing were among the areas where startups scored outsized rounds. For the fourth quarter, the largest early-stage rounds hailed from the biotech space. This past quarter, for instance, Elon Musk ’s artificial intelligence startup xAI picked up $134.7

Biotech 102

Biotech Generative AI Insurance Artificial Intelligence 102

TechCrunch

JANUARY 31, 2022

It’s also a key pillar of Gandeeva, a new biotech company that emerged from stealth on Monday with a $40 million Series A round. The company plans to combine this high-resolution imagery with a suite of machine learning tools to speed up the process of drug discovery. “It Image Credits: Gandeeva Therapeutics.

Artificial Inteligence 231

Artificial Inteligence Machine Learning Biotech Government 231

TechCrunch

MAY 28, 2021

The city’s tech ecosystem appears to have a robust space for machine learning, artificial intelligence, biomedicine, fintech, travel tech, oil, renewables, e-commerce, gaming, health tech, deep tech, space tech and insurtech. Strong in machine learning/AI/digital. Lysimachos Zografos, founder, Parkure.

Technical Review 235

Technical Review Artificial Inteligence Weak Development Team Fintech 235

Crunchbase News

MAY 6, 2024

Berkshire Grey , a developer of robotics technology for warehouses, made its market debut via SPAC merger in July 2021. Greenlight Biosciences , a biotech developing RNA products for health and agriculture, went public in early 2022 near the tail end of the SPAC boom, at an initial valuation around $1.2 It didn’t go well.

Biotech 114

Biotech Case Study Marketing Study 114